PYC Therapeutics Limited
PYCXF
$0.8462
$0.178626.75%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 2.75% | -14.90% | -0.21% | -51.29% | 0.48% |
| Total Depreciation and Amortization | -2.73% | -59.00% | 0.21% | 119.43% | -0.45% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -2.75% | 204.03% | -0.20% | -202.90% | -0.47% |
| Change in Net Operating Assets | -- | -- | -0.21% | -- | -- |
| Cash from Operations | 2.75% | 45.51% | -0.21% | -368.46% | 0.47% |
| Capital Expenditure | 2.74% | -2,670.33% | 0.00% | 90.01% | 0.44% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 2.74% | -2,670.33% | 0.00% | 90.01% | 0.44% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 0.00% | -8.54% | 0.00% | -17.75% | 0.00% |
| Issuance of Common Stock | -- | -- | 0.00% | 329.07% | 0.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 0.00% | -- | -- |
| Cash from Financing | 2.76% | -100.24% | 0.21% | 326.26% | -0.47% |
| Foreign Exchange rate Adjustments | -2.80% | 5.41% | 0.20% | 202.42% | 0.50% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 2.75% | -143.21% | 0.21% | 325.09% | -0.47% |